Phathom Pharmaceuticals
Tom Harris is the former Senior Vice President and Head of Global Regulatory Affairs at Takeda, where he was responsible for all global regulatory matters at Takeda while overseeing regulatory personnel in the US, Europe, Japan, and Singapore from 2012 to 2019.
Previously, Mr. Harris held multiple positions of increasing responsibility over 19 years within Abbott International’s Global Regulatory Affairs function. He held the position as the Global Regulatory Head for the Abbott Immunology franchise, which included oversight and responsibility for the worldwide submissions of HUMIRA® for rheumatology, gastroenterology, and dermatology indications. He also served as the Global Project Head leading Humira Global Project Teams in dermatology and new indications in spondyloarthropathies and uveitis. Before joining the industry, Mr. Harris was a staff pharmacist at Good Shepherd Hospital in Barrington, IL.
Mr. Harris earned a B.S. in Pharmacy from the University of Iowa College of Pharmacy.
This person is not in any offices
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid.